World-class research. Ultimate impact.
More on impact ›

Review ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Cardiovasc. Med. | doi: 10.3389/fcvm.2019.00152

Direct Percutaneous Mitral Annuloplasty in Patients with Functional Mitral Regurgitation: When and How

 Tomasz Gasior1, 2*, Mara Gavazzoni1,  Maurizio Taramasso1, Michel Zuber1 and Francesco Maisano1
  • 1University Heart Center Zürich, Switzerland
  • 2Department of Cardiology and Structural Heart Diseases, School of Medicine in Katowice, Medical University of Silesia, Poland

Mitral regurgitation (MR) is a frequent valvular disease among patients deemed too high risk for surgery. Echocardiography along with CT is the primary diagnostic tool for MR and offers a comprehensive 3D assessment in patient selection and screening for the optimal treatment method. The direct percutaneous mitral annuloplasty addresses the underlying mechanisms of functional mitral regurgitation with a less invasive, catheter-based approach. The described here devices proved a satisfactory safety profile, provided significant MR reduction in most of the patients, and were associated with a significant improvement of symptoms. Although long term outcome assessment is needed to support these early reports, the percutaneous mitral annuloplasty is likely to set a new standard of treatment in the forthcoming future.

Keywords: direct percutaneous annuloplasty, Mitral regurgitation, mitral valve imaging, transcatheter valve repair, functional mitral regurgitation

Received: 02 May 2019; Accepted: 07 Oct 2019.

Copyright: © 2019 Gasior, Gavazzoni, Taramasso, Zuber and Maisano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: MD. Tomasz Gasior, University Heart Center Zürich, Zurich, 8091, Zürich, Switzerland, tgasior@gmail.com